![]() |
市場調查報告書
商品編碼
1520525
2024-2032 年按類型、應用、最終用戶和地區分類的製藥機器人市場報告Pharmaceutical Robots Market Report by Type, Application, End User, and Region 2024-2032 |
IMARC Group年,全球製藥機器人市場規模達1.985億美元。對藥品的需求不斷成長、機器人技術的新興技術進步以及為確保生產過程中產品安全和品質而實施嚴格的監管框架是推動市場的一些主要因素。
主要市場促進因素:製藥機器人市場的擴大主要是由於藥物需求的增加,這可歸因於老年人口的成長和慢性病病例的增加。此外,製造流程效率、精度和生產力的提高進一步刺激了市場成長。
主要市場趨勢:機器人技術應用於最精確的任務,包括藥物配方和包裝。將人工智慧和機器學習等先進技術整合到機器人技術中可以提高營運效率並減少人為錯誤。
地理趨勢:由於不斷的工業擴張和對醫療保健技術的巨大投資,亞太地區正在成為最大的市場參與者。中國、日本和韓國等其他一些國家在這一領域處於領先地位,因為它們的政府支持將機器人解決方案與先進技術結合到製藥中。
競爭格局:競爭格局的特點是產業主要參與者的參與,他們透過加強產品創新和與多個合作夥伴的合作定期提高其市場地位。雖然這些公司顯然正在投資技術創新,但他們也決心提高客戶支援和服務的標準,以鞏固他們在市場上的地位。
挑戰與機會:市場面臨挑戰,包括高昂的前期成本以及將機器人與現有系統整合所帶來的複雜性,但同時也提供了大量機會。基於創建更靈活和可擴展的機器人解決方案,可以滿足不斷發展的行業的需求並跟上不斷變化的法規,因此存在充足的成長機會。
醫藥產品的需求不斷成長
由於機器人技術的使用驅動機械整合,製藥業發生了巨大的轉變,直接導致製藥機器人市場的成長。隨著全球人口老化和慢性病的增加,對藥品的需求不斷增加。這帶動了市場需求。醫學的巨大成長進一步增強了這一點,將創新藥物療法納入其可以對抗的疾病清單中,包括個人化藥物和複雜的生物製藥。借助機器人技術,藥品製造過程實現了效率和準確性的提高,從而提高了製藥機器人的市場佔有率。根據國際機器人聯合會(IFR)的數據,全球專業服務機器人市場營業額達67億美元,2020年成長12%。
機器人技術的新興技術進步
配備感測和控制能力等先進技術的機器人可以提高藥品製造和配藥等流程的精度和標準化。這種能力可以最大限度地減少人為錯誤,並顯著提高產品品質和患者安全,這是製藥機器人市場的主要趨勢之一。機器人技術的發展至關重要,因為它們有助於解決製藥業面臨的挑戰。機器人的使用還可以取代勞動密集和重複性任務,從而最大限度地提高資源利用率,從而加快生產週期。主要公司為提高效率和生產力而進行的轉變有助於他們產生更高的製藥機器人市場收入。
實施嚴格的監管框架
監管機構透過建立嚴格的法律架構構成市場的重要決定因素。這些法規規定了藥品的安全性、有效性和質量,迫使藥廠採用機器人技術來滿足既定要求。製藥業的機器人技術由具有與工業自動化領域類似功能的技術組成,包括即時監控和資料記錄,這對於確保自動化製藥過程的合規性和可靠性至關重要。這些技術的實施對於滿足監管機構規定的嚴格要求起著至關重要的作用,這凸顯了製藥機器人市場分析。
IMARC Group提供了全球製藥機器人市場報告各細分市場主要趨勢的分析,以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據類型、應用程式和最終用戶對市場進行了分類。
傳統機器人
關節式機器人
SCARA機器人
台達/並聯機器人
笛卡兒機器人
雙臂機器人
協作製藥機器人
傳統機器人代表最受歡迎的類型
該報告根據類型提供了詳細的市場細分和分析。這包括傳統機器人(關節式機器人、SCARA機器人、三角/並聯機器人、直角座標機器人、雙臂機器人)和協作製藥機器人。報告顯示,傳統機器人佔據最大的市場。
傳統機器人是製藥業最常使用的機器人類型,機器人自動執行日常流程的任務。此類機器人因其無與倫比的能力而被廣泛應用於製藥行業,因為它們在處理製藥製造中通常需要的不同類型的自動化任務方面已經證明了可靠性和效率。市場報告顯示,機器人的多方面工作和準確度是其突出的原因,佔據了相當大的市場佔有率。製藥機器人市場預測顯示,傳統機器人仍是最受歡迎的類型,這得益於各大品牌不斷升級和提高效率,試圖滲透到更複雜的製藥流程。
揀選和包裝
藥品檢驗
實驗室應用
揀選和包裝目前佔據最大的市場佔有率
報告還提供了基於應用程式的詳細市場細分和分析。這包括揀選和包裝、藥品檢查以及實驗室應用。報告稱,揀選和包裝佔據了最大的市場佔有率。
製藥機器人市場概況表明,涉及揀選和包裝的這些操作是最主要的應用。該細分市場受益於機器人技術的實施,因為這些系統提高了藥品包裝的速度、準確性和一致性。此外,未來的市場機會可能會透過機器人的進一步設計創新來處理和減少停機時間,從而提高藥品製造的整體生產力。製藥業市場報告強調了該技術在此類製造過程中提供的優勢,特別是在提高生產效率和降低營運成本方面。
製藥公司
研究實驗室
製藥公司佔最大的市場佔有率
報告還提供了基於最終用戶的詳細市場細分和分析。這包括製藥公司和研究實驗室。報告顯示,製藥公司佔了最大的市場佔有率。
根據市場估計,製藥公司在機器人市場中佔有最大佔有率。他們利用機器人技術在生產、精確度以及遵守安全和健康標準和法規方面提出增強的應用。市場報告表明,隨著越來越多的製藥公司受到創新和成本效益的激勵,機器人整合將變得更加成熟。製藥機器人市場最近的機會包括機器人用途的開發,這可能會產生更客製化和複雜的解決方案,旨在滿足製藥生產商的特殊需求。
北美洲
美國
加拿大
亞太
中國
日本
印度
韓國
澳洲
印尼
其他
歐洲
德國
法國
英國
義大利
西班牙
俄羅斯
其他
拉丁美洲
巴西
墨西哥
其他
中東和非洲
亞太地區在市場上表現出明顯的主導地位
市場研究報告還對所有主要區域市場進行了全面分析,其中包括北美(美國和加拿大);歐洲(德國、法國、英國、義大利、西班牙、俄羅斯等);亞太地區(中國、日本、印度、韓國、澳洲、印尼等);拉丁美洲(巴西、墨西哥等);以及中東和非洲。報告稱,亞太地區是製藥機器人最大的區域市場。
亞太地區由於工業成長快速以及對醫療保健和藥品製造的推動更加強烈,在市場上佔據主導地位。根據製藥機器人市場回顧,中國、日本和韓國這三個領先國家在製藥操作中應用機器人技術處於領先地位。製藥機器人報告描述了極大促進該領域區域市場擴張的政府行動和投資。由於藥品需求的增加以及機器人領域的技術突破,亞太地區的製藥機器人市場前景仍然樂觀。根據自動化推進協會(A3)的報告,北美公司近年來訂購了 44,196 台機器人,價值 23.8 億美元,與 2021 年相比,數量增加了 11%,價值增加了 18%。
The global pharmaceutical robots market size reached US$ 198.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 445.0 Million by 2032, exhibiting a growth rate (CAGR) of 9.2% during 2024-2032. The rising demand for pharmaceutical products, the emerging technological advancement in robotics technology, and the implementation of stringent regulatory frameworks to ensure product safety and quality during production processes are some of the major factors propelling the market.
Major Market Drivers: The market for pharmaceutical robots is expanding primarily due to an increasing demand for medications, which can be attributed to the growing elderly population and a rise in chronic disease cases. Additionally, enhancements in the efficiency, precision, and productivity of manufacturing processes further stimulate market growth.
Key Market Trends: Robotic technology finds its application in the most accurate tasks including drugs formulation and packaging. Integrating the advanced technologies, such as AI and machine learning in robotics is improving operational efficiency and reducing the human error as well.
Geographical Trends: Asia Pacific is emerging as the biggest market player, due to the constant industrial expansion and huge investment in healthcare technology. Some other countries such as China, Japan, and South Korea are leading the way in this area, as their governments are backing the incorporation of robotic solutions with the advanced technologies into drug making.
Competitive Landscape: The rivalry landscape is characterized by the involvement of major players in the industry who increase their market positions periodically via enhanced product innovations and collaboration with multiple partners. While these companies are clearly investing in technological innovations, they are also determined to raise the bar in customer support and services to fortify their hold on the market.
Challenges and Opportunities: The market has challenges that include high upfront costs and the complexity that comes with integrating robots with existing systems, but at the same time provide numerous opportunities. There are ample growth opportunities based on creating more flexible and scalable robotic solutions which can serve the needs of growing industries and keep abreast with constantly changing regulations.
The rising demand for pharmaceutical products
The pharmaceutical industry witnesses a dramatic shift due to machinery integration driven by the use of robotics technology, directly leading to the pharmaceutical robots market growth. With the aging global population and rising chronic diseases, the demand for pharmaceuticals is rising. This drives the market demand. This is further augmented by tremendous growth in medicine that has incorporated innovative pharmacotherapies into the list of diseases that they can combat, including personalized medicines and complex biopharmaceuticals. With the help of robotics technology, the pharmaceutical manufacturing processes achieve an increase in efficiency and accuracy, and consequently improve the pharmaceutical robots market share. According to the International Federation of Robotics (IFR), the global market for professional service robots reached a turnover of $6.7 billion U.S. dollars, marking a 12% increase in 2020.
The emerging technological advancement in robotics technology
Robots equipped with advanced technologies, including sensing and control capabilities, enhance precision and standardization in processes such as drug manufacturing and dispensing. Such ability minimizes human error and considerably improve product quality and patient safety, which is one of the major pharmaceutical robots market trends. The developments in robotics technology are essential as they contribute to the solutions of the challenges facing the pharmaceutical industry. The employment of robots as well ensures the substitution of labor-intensive and repetitive tasks with them, hence maximizing resource utilization which in turn speeds up production cycle. This transition of the key companies to enhance their efficiencies and their productivity helps them generate higher pharmaceutical robots market revenue.
The implementation of stringent regulatory frameworks
Regulatory authorities constitute an important determinant for the market through the establishment of strict legal frameworks. These regulations stipulate the safety, efficacy, and quality of pharmaceutical products, forcing pharmaceutical manufacturers to adopt robotics technology to meet the set requirements. Robotics in pharmaceutical industry consist of technologies with functions that are similar to what is found within the industrial automation sector, including real time monitoring and data logging which are very essential in ensuring the compliance and satisfying the reliability of the automated pharmaceutical manufacturing processes. The implementation of these technologies plays a crucial role in satisfying the strict requirements prescribed by the regulatory authorities, which highlights the pharmaceutical robots market analysis.
IMARC Group provides an analysis of the key trends in each segment of the global pharmaceutical robots market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, application, and end user.
Traditional Robots
Articulated Robots
SCARA Robots
Delta/Parallel Robots
Cartesian Robots
Dual-arm Robots
Collaborative Pharmaceutical Robots
Traditional robots represent the most popular type used
The report has provided a detailed breakup and analysis of the market based on the type. This includes traditional robots (articulated robots, SCARA robots, delta/parallel robots, cartesian robots, dual-arm robots), and collaborative pharmaceutical robots. According to the report, traditional robots accounted for the largest market share.
Traditional robots are the most frequently used type of robots in the pharmaceutical industry where robots automate tasks for routine processes. Such robots are widely utilized in the pharmaceutical industry for their unmatched capacity due to their already proved reliability and efficiency in handling different types of automated tasks normally necessary in pharmaceutical manufacturing. The market report revealed that the multifaceted work of the robots which is consistent with accuracy has been the reason behind their prominence occupying a substantial portion of the market for themselves. The pharmaceutical robots market forecast shows that it remains the traditional robots to be the most preferred type, which can be attributed to constant upgrade and increase efficiency by major brands trying to penetrate in more complicated processes in pharmaceuticals.
Picking and Packaging
Inspection of Pharmaceutical Drugs
Laboratory Applications
Picking and packaging presently account for the largest market share
A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes picking and packaging, inspection of pharmaceutical drugs, and laboratory applications. According to the report, picking and packaging accounted for the largest market share.
The pharmaceutical robots market overview unveils that these operations involved in picking and packaging are the top dominant applications. This segment benefits greatly from implementing robotics, as these systems improves speed, accuracy, and consistency in the packaging of pharmaceutical products. In addition, future market opportunities may be signified by further designed innovations in robot to handle and reduce the downtime, which can be as this to improve the whole productivity of pharmaceutical manufacturing. The pharmaceutical industry market report underlines the advantage which this technique provides in this kind of manufacturing processes especially on increased production efficiency along with reduced cost of operation.
Pharmaceutical Companies
Research Laboratories
Pharmaceutical companies hold the largest share of the market
A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes pharmaceutical companies and research laboratories. According to the report, pharmaceutical companies accounted for the largest market share.
The pharmaceutical companies hold the biggest share in the robot's market, according to the market estimation. They utilize robotic technology to come up with enhanced applications in the area of production, precision, and adherence of the safety and health standards and regulations. The market report indicates that as more pharmaceutical companies are motivated by innovation and cost-efficiency, robotic integration will become even more established. Pharmaceutical robots market recent opportunities include the development of robotic uses that might give rise to more tailored and intricate solutions aimed to meet the particular needs of pharmaceutical producers.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Asia Pacific exhibits a clear dominance in the market
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific represents the largest regional market for pharmaceutical robots.
Asia Pacific region holds the dominance in the market on account of the fast industrial growth and more intense push towards healthcare and pharmaceutical manufacturing. In line with the pharmaceutical robot market review, the three leading nations including China, Japan and South Korea are at the forefront in implementing robotics in pharmaceutical operations. The pharmaceutical robots report describes government actions and investments that greatly contribute to regional market expansion in this field. The pharmaceutical robots market outlook for Asia Pacific remains positive due to an increasing demand for pharmaceuticals along with technological breakthroughs witnessed in the field of robotics. According to a report from the Association for Advancing Automation (A3), North American companies ordered 44,196 robots, valued at $2.38 billion in a recent year, marking increases of 11% in units and 18% in value compared to 2021.
ABB Ltd.
DENSO Corporation
FANUC Corporation
Kawasaki Heavy Industries Ltd.
Kuka AG
Marchesini Group S.p.A
Mitsubishi Electric Corporation
Robert Bosch GmbH
Seiko Epson Corporation
Shibuya Corporation
Universal Robots A/S (Teradyne Inc.)
Yaskawa Electric Corporation
(Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.)
Key pharmaceutical robots companies are proactively strengthening their positions within the industry by leveraging the trend and push forward with innovation. These key players are investing heavily for the integration of the latest technologies such as artificial intelligence, machine learning, and advanced sensors into their robotics products. Moreover, the companies are focused on building customer relationships via all-inclusive support services such as training, maintenance, and troubleshooting which are so vital for high performance and customer satisfaction. Apart from customer service, these major players are seriously involved in thought leadership, which include publishing research papers, attending industry conferences, and hosting webinar. These activities allow them to improve their reputations and enhance their credibility and establish their trust in the marketplace is integral here. Such efforts are significant components of the pharmaceutical robots market recent developments.
In February 2021, Kawasaki Heavy Industries Ltd. announced the installation of Japan's first automated polymerase chain reaction (PCR) testing system for the coronavirus disease (COVID-19), which operates using Kawasaki-made robots, at Fujita Health University in Aichi Prefecture.
In February 2021, ABB Ltd. launched two new additions to its robot line-up and the firm expected a 90% increase in robot sales in China relying on cobots or collaborative robots for pharmaceutical automation, for faster, scalable, and energy efficient manufacturing.
In August 2022, Yaskawa Electric Corporation announced the opening of a brand-new robotic solution facility in Haryana, India which enables closer collaboration and accelerated development of solutions for the full range of industrial robotic applications offered by the company.